dr.llaguna

Surgical oncologist specializing in GI & skin malignancies. Director, Surgical Oncology, HCA FL Kendall Hospital. Assist Professor of Surgery @FIUMedicine

[dr.llaguna @DrLlaguna]

https://t.co/BpJADzEi2Q

[dr.llaguna @DrLlaguna]

https://t.co/ms8pSUZJlW

[dr.llaguna @DrLlaguna]

https://t.co/hbx1GzlTML

[Society of Surgical Oncology @SocSurgOnc]

🎙️ New on SurgOnc Today!

Drs. Alissa Greenbaum and Omar Llaguna host Drs. Maheswari Senthil and Richard Alexander to explore the history of HIPEC and PIPAC in the U.S. and the ethical challenges of bringing experimental therapies into practice.

Listen: https://t.co/G4RAIrUoPj

[dr.llaguna @DrLlaguna]

https://t.co/qIrAoyOmUP

[dr.llaguna @DrLlaguna]

The day is finally here! Our @histosonics Edison has arrived, been calibrated, and placed in its new home im OR #6.

[dr.llaguna @DrLlaguna]

https://t.co/4jUyKb8yxY

[dr.llaguna @DrLlaguna]

https://t.co/8fTFrREoNO

[dr.llaguna @DrLlaguna]

https://t.co/4QgEi3PPS6

[BJS Open @BjsOpen]

Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis
➡️https://t.co/3La43SYJaq

Piperacillin/tazobactam as antimicrobial prophylaxis significantly lowers the risk of postoperative surgical-site infections, major surgical complications (complications classified as Clavien–Dindo grade greater than or equal to III), clinically relevant postoperative pancreatic fistulas (grades B and C), and mortality, hence supporting the implementation of piperacillin/tazobactam for surgical prophylaxis in current practice.

👏👏👏@JayKumar_MD_PhD, Isabella Reccia, Adriano Carneiro, Mauro Podda, Francesco Virdis, Nikolaos Machairas, David Nasralla, Ramesh P Arasaradnam, Kenneth Poon, Christopher J Gannon, John J Fung, Nagy Habib, Omar Llaguna

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @me4_so @for_surgery @for_surgeons @modern_surgeon @surggpt #some4hpb #some4tpl @hpb_so #PancreaticCancer #Pancreatitis @YouppiePancreas @German_PancClub @surgery_hps #PancreasClub2023 @PancreasClub @EurPancClub @P_C_E_ @dice_europe @DPCG_official @pancreatitis_nl @PanCAN #PanCANawareness

[dr.llaguna @DrLlaguna]

Congrats to my co-authors for another work well done. Our study suggests that although palliative care can provide a survival benefit for patients with unresectable pancreatic cancer, the current rate of palliative care utilization stands at a mere 24.3%.

[dr.llaguna @DrLlaguna]

Our study found that both minimally invasive and converted to open surgeries were associated with better long-term survival rates, compared to traditional open surgery. The study found that conversion from minimally invasive to open surgery did not negatively affect outcomes

[dr.llaguna @DrLlaguna]

Happy Hanukkah! 🕎 @ Memorial Healthcare System https://t.co/6kkAUbPg2d

[dr.llaguna @DrLlaguna]

New @AnnSurgOncolAnnals publication. Impact of Textbook Oncologic Outcome Attainment on Survival After Gastrectomy: A Review of the National Cancer Database. Thanks to everyone that helped put it together #drllaguna #drgannon #surgicaloncology @megancibulas

[dr.llaguna @DrLlaguna]

Sun Safety and Skin Cancer - July Webinar https://t.co/GA8JixJaKn

[dr.llaguna @DrLlaguna]

Congratulations to our 3rd year surgical resident Megan Cibulas for her virtual podium presentation at this years American College of Surgeons Clinical Congress @mhshospital #ACSCC2021 #drllaguna

[Fight Colorectal Cancer @FightCRC]

Research led by @yincaoScD shows that young adults who drink sugary beverages may be at an increased risk of developing colon cancer. Those who drank two or more per drinks per day had over twice the risk of developing early-onset colorectal cancer.

https://t.co/KyTUjh1bzG

[dr.llaguna @DrLlaguna]

Just posted a photo @ Memorial Healthcare System https://t.co/4wleiSujBr

[dr.llaguna @DrLlaguna]

Just posted a photo @ Memorial Healthcare System https://t.co/GwzAz2ADoX

[dr.llaguna @DrLlaguna]

Presented at the 38th Annual Miami Breast Cancer Conference. Proud of our residents work on this abstract and upcoming paper